ClinicalTrials.Veeva

Menu

Study of Oxidized Albumin in Liver Transplant Patients (SALT)

R

Region Stockholm

Status

Not yet enrolling

Conditions

Liver Cirrhosis
Liver Failure
Liver Transplant Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT06772298
K 2024-3904

Details and patient eligibility

About

The overall goal is to describe the oxidation state of albumin before, during and after liver transplantation. This is a pilot observational study in which the oxidative state in 10 patients undergoing liver transplantation will be described. Samples for analysing the oxidation state of albumin, general oxidative damage and anti-oxidant state, the activation of the complement system and factors involved in coagulation will be obtained before transplantation, before and after reperfusion of the portal vein and on postop days 1, 2 and about 30.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients on waiting list for liver transplantation

Exclusion criteria

  • none

Trial contacts and locations

0

Loading...

Central trial contact

Håkon Haugaa, MD, PhD; Olav Rooijackers, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems